Skip to main content
Veterinary Medicines

EURICAN DAPPi-L lyofilizát a suspenzia na injekčnú suspenziu pre psy

Not authorised
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
  • Canine parainfluenza virus, strain CGF 2004/75, Live
  • Canine parvovirus, strain CAG2, Live
  • Canine adenovirus 2, strain DK13, Live
  • Canine distemper virus, strain BA5, Live

Product identification

Medicine name:
EURICAN DAPPi-L lyofilizát a suspenzia na injekčnú suspenziu pre psy
Active substance:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
  • Canine parainfluenza virus, strain CGF 2004/75, Live
  • Canine parvovirus, strain CAG2, Live
  • Canine adenovirus 2, strain DK13, Live
  • Canine distemper virus, strain BA5, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
    1.00
    European Pharmacopoeia Unit(s)
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
    1.00
    European Pharmacopoeia Unit(s)
    /
    1.00
    millilitre(s)
  • Canine parainfluenza virus, strain CGF 2004/75, Live
    4.70
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine parvovirus, strain CAG2, Live
    4.90
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine adenovirus 2, strain DK13, Live
    2.50
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine distemper virus, strain BA5, Live
    4.00
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
      • Not applicable
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Authorisation status:
  • Surrendered
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/052/04-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 17/12/2021